Skip to content Skip to footer
Join our LinkedIn Group and be part of the conversation on AI in life sciences
Login
Login
Close
ISPOR 2026_ Hereditary Angioedema Patient Burden – Social Media Analysis

ISPOR 2026: Hereditary Angioedema Patient Burden – Social Media Analysis

BlogJuly 2, 2026109Views0Likes0Comments
Hereditary Angioedema patient burden remains a significant challenge for those living with this rare, unpredictable condition, even as new treatments emerge. At MadeAi, we specialize in turning real-world patient conversations into actionable intelligence. Our latest social media listening analysis, presented at ISPOR USA 2026, reveals how HAE continues to affect daily lives while highlighting opportunities…

Read More

AI-Augmented Literature Reviews

ISPOR 2026: AI-Augmented Reviews—A Multi-Project Analysis of Speed, Accuracy, and Workflow

BlogJune 25, 202681Views0Likes0Comments
AI-augmented literature reviews are transforming evidence generation across life sciences. This blog explores multi-project analysis of AI-assisted literature reviews. It examines improvements in review speed, screening accuracy, traceability, and workflow efficiency while maintaining rigorous human oversight for submission-ready outcomes. For teams in health economics and outcomes research (HEOR), regulatory affairs, and evidence generation, systematic literature…

Read More

Identifying Drug Repurposing Opportunities with AI Literature Review

ISPOR 2026: Identifying Drug Repurposing Opportunities with AI Literature Review

BlogJune 17, 2026112Views0Likes0Comments
AI-Assisted Drug Repurposing What if the next breakthrough treatment is already available today, hidden within existing drugs and waiting to be discovered? This question drives the growing field of AI-assisted drug repurposing, a smart and cost-effective strategy that looks for new therapeutic uses for approved medications. Unlike traditional drug development, which can cost billions and…

Read More

Evaluating the MadeAi Platform for Literature Screening of a Class II Medical Device

ISPOR 2026: Evaluating MadeAi for Literature Screening of a Class II Medical Device

BlogJune 9, 2026128Views0Likes0Comments
What is AI-assisted literature screening for Class II medical devices? AI Literature Screening for Medical Devices is the application of artificial intelligence to identify, review, classify, and prioritize scientific literature relevant to a medical device. This reduces the manual effort required for evidence generation and regulatory review workflows. For instance, AI analyzes titles, abstracts, and…

Read More

The AI Evaluation Problem in Evidence Synthesis

The AI Evaluation Problem in Evidence Synthesis

BlogJune 3, 2026155Views0Likes0Comments
Why the Industry is Testing the Wrong Thing The life sciences industry faces a growing paradox: organizations are investing heavily in AI, yet many evaluation methods fail to measure how these systems actually perform in real-world evidence synthesis workflows. Every week, new evaluations emerge, and task forces publish guidelines. Academic papers rank AI tools. Organizations…

Read More

systematic-literature-review-process

How to Do an AI-Assisted Systematic Literature Review: A Step-by-Step Guide

BlogMay 14, 2026172Views0Likes0Comments
The Systematic Literature Review Definition: Systematic Literature Review (SLR) is a rigorous, structured, and transparent process of identifying, analyzing, and synthesizing all existing research on a clearly defined question or topic, providing a comprehensive summary and critical evaluation of the evidence. If you’ve ever tried to pull together evidence for a big research question, you’ll…

Read More